Broad lipid metabolic pathways

Broad lipid metabolic pathways encompass the complex network of biochemical processes involved in the synthesis, degradation, and transport of lipids within an organism (StatPearls, 2023). These pathways include fatty acid metabolism, cholesterol biosynthesis, and the regulation of lipoproteins, which are essential for maintaining cellular membrane integrity, energy storage, and signaling (NIH, 2022). Dysregulation of these pathways is a primary driver of metabolic disorders such as atherosclerosis, obesity, and non-alcoholic fatty liver disease (Nature Reviews Endocrinology, 2021). While the term itself describes a broad biological process rather than a single molecular target, it encompasses numerous validated therapeutic targets such as HMG-CoA reductase, PCSK9, and PPAR receptors. Pharmacological intervention in these pathways is a cornerstone of cardiovascular disease prevention and the management of metabolic disorders (Journal of Lipid Research, 2020). Understanding the interplay between these pathways is crucial for developing multi-target or systemic therapies for complex metabolic diseases.

Other names

Lipid metabolismLipid metabolic processesFatty acid metabolismCholesterol metabolismLipid homeostasis

Drugs acting within these pathways function by inhibiting rate-limiting enzymes (e.g., HMG-CoA reductase), modulating nuclear receptor activity (e.g., PPARs) to alter gene expression, or inhibiting protein-mediated transport of lipids across membranes (Pharmacological Reviews, 2018).